Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Hematol ; 78(6): 275-8, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10422630

ABSTRACT

The production of erythropoietin (Epo), the glycoprotein hormone which controls red blood cell formation, is regulated by feedback mechanisms sensing tissue oxygenation. The mechanism of the putative oxygen sensor has yet to be elucidated. There is evidence that at least two pathways participate in hypoxia signal transduction. One appears to involve a specific haem protein, and a second implicates reactive oxygen species (ROS). Iron catalyses the generation of intracellular ROS and therefore alters the cellular redox state. We have investigated the effect of modulating intracellular iron content on Epo production in Hep 3B cells. Iron chelation stimulates Epo production at 20% O2 and enhances Epo production at 1% O2, but it has no additive effect on cobalt-induced Epo production. Excess molar iron inhibited Epo production in response to hypoxia, desferrioxamine (DFO) and cobalt chloride and inhibited the DFO-enhancing effect of hypoxia-induced Epo production. We found that sulphydryl oxidising agents exert a differential inhibitory effect on hypoxia-induced versus DFO-induced Epo production, providing further evidence that multiple pathways of oxygen sensing exist.


Subject(s)
Erythropoietin/biosynthesis , Chelating Agents/pharmacology , Cobalt/pharmacology , Deferoxamine/pharmacology , Humans , Iron Chelating Agents/pharmacology , Oxygen , Partial Pressure , Reactive Oxygen Species/physiology , Sulfhydryl Reagents/pharmacology , Tumor Cells, Cultured
2.
Mol Genet Metab ; 67(2): 113-7, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10356310

ABSTRACT

Erythropoietin (Epo), a glycoprotein hormone produced principally in the fetal kidney and in the adult liver in response to hypoxia, is the prime regulator of growth and differentiation in erythroid progenitor cells. The regulation of Epo gene expression is not fully understood, but two mechanisms have been proposed. One involves the participation of a heme protein capable of reversible oxygenation and the other depends on the intracellular concentration of reactive oxygen species (ROS), assumed to be a function of pO2. We have investigated the production of Epo in response to three stimuli, hypoxia, cobalt chloride, and the iron chelator desferrioxamine, in Hep3B cells. As expected, hypoxia caused a marked rise in Epo production. When the cells were exposed to the paired stimuli of hypoxia and cobalt no further increase was found. In contrast, chelation of iron under hypoxic conditions markedly enhanced Epo production, suggesting that the two stimuli act by separate pathways. The addition of carbon monoxide inhibited hypoxia-induced Epo production, independent of desferrioxamine concentration. Taken together these data support the concept that pO2 and ROS are sensed independently.


Subject(s)
Erythropoietin/biosynthesis , Erythropoietin/genetics , Gene Expression Regulation , Oxygen/metabolism , Carcinoma, Hepatocellular , Cell Hypoxia/drug effects , Cell Hypoxia/genetics , Cycloheximide/pharmacology , Deferoxamine/pharmacology , Erythropoietin/metabolism , Gene Expression Regulation/drug effects , Humans , RNA, Messenger/biosynthesis , Transcription, Genetic/drug effects , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...